• June 2002

    In collaboration with WHO and the Ministry of Health launched ‘Homapak’ a sulfadoxine pyrimethamine + chloroquine combination therapy formulated in age-specific single-use dosage packs for children between the age of 2 months and 5 years. This has been the flagship brand in the Home Based Management of Fever strategy launched in the same year which resulted in an increase in children receiving treatment within 24 hours from 7.3% in 2001 to 55% nationally by the year 2005.

  • January 2006

    Commenced contract manufacturing of anti-malarials and injectables

  • March 2006

    Commissioned a Formulation Development Laboratory equipped with stability chambers for accelerated and real time stability studies (First in Uganda)

  • August 2006

    First to Locally manufacture and launch an Artemesinin Combination Treatment called Duact (Artesunate + Amodiaquine) in Uganda.

  • February 2008

    Commenced contract packaging of Medical diagnostic devices and reagents.

  • March 2008

    Launched the first Diabetic drug manufactured in Uganda: Formin (Metformin Hcl) for treatment of Type II Diabetes Mellitus.

  • September 2009

    Launched the first Anti-hypertensive manufactured in Uganda: Cardipac (Amlodipine)

  • January 2010

    Launched our official Code of Ethics, “Producing medicines with integrity”.

  • August 2010

    Winner of the international Frost & Sullivan product leadership of the year award, healthcare industry, Uganda.

  • May 2011

    Opened a state of the art secondary packaging facility for third party contract packaging of medical products. Currently we carry out secondary packaging of: reproductive health items i.e. Condoms, Oral and Parenteral Contraceptives.

  • 2012

    Registered 4 new products Amoxikid, Kamadol Kids, Kamadol Junior and Cardipac 10

  • 2014

    Registered Vitacee

  • 2015

    Umbigel an antiseptic for umblical cords

  • 2016

    Registered Kamadol plus